EUVIMEDEUVIMED entdecken
Crossref

Frequency of dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase 1A1 variants in cancer patients requiring chemotherapy: A single-center study in southern India

Kevin Nischay Gangavarapu, Nandini Shyamali Bora, Srinivas Maddali, Qurratulain Hasan

Journal of Clinical and Basic Research · 2023

DOI: 10.61186/jcbr.7.1.6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Basic Research, 2023. Verfasst von Kevin Nischay Gangavarapu und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gangavarapu, K. N., Bora, N. S., Maddali, S., & Hasan, Q. (2023). Frequency of dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase 1A1 variants in cancer patients requiring chemotherapy: A single-center study in southern India. Journal of Clinical and Basic Research. https://doi.org/10.61186/jcbr.7.1.6

Vancouver

Gangavarapu KN, Bora NS, Maddali S, Hasan Q. Frequency of dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase 1A1 variants in cancer patients requiring chemotherapy: A single-center study in southern India. Journal of Clinical and Basic Research. 2023. doi:10.61186/jcbr.7.1.6

BibTeX
@article{Gangavarapu2023,
  author = {Gangavarapu, Kevin Nischay and Bora, Nandini Shyamali and Maddali, Srinivas and Hasan, Qurratulain},
  title = {Frequency of dihydropyrimidine dehydrogenase and UDP-glucuronosyltransferase 1A1 variants in cancer patients requiring chemotherapy: A single-center study in southern India},
  journal = {Journal of Clinical and Basic Research},
  year = {2023},
  doi = {10.61186/jcbr.7.1.6}
}
Kostenlos starten →